e-learning
resources
ERS Research Seminars
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alternatives to animal studies: virtual lung, human cells, in silico?
A. Holmes (London, United Kingdom)
Source:
Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Number:
3
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Holmes (London, United Kingdom). Alternatives to animal studies: virtual lung, human cells, in silico?. Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Utilising data from single cell approaches to study existing and recently emerging lung diseases?
Source: Virtual Congress 2021 – Utilising data from single cell approaches to study existing and recently emerging lung diseases?
Year: 2021
Lung function measurements in mouse models of lung disease: What to expect from FEV0.1?
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Breathprinting of multiple bacterial lung pathogens in vitro and in mice: what we can learn from translational approaches
Source: International Congress 2014 – Usefulness of exhaled volatile organic compounds (VOCs) for the monitoring and understanding of lung diseases
Year: 2014
Progress and applications of mouse models for human lung cancer
Source: Eur Respir J 2010; 35: 426-443
Year: 2010
Imaging of animal models: in vivo we can learn more
Source: Annual Congress 2008 - Computer-aided imaging of lung parenchyma and airways
Year: 2008
Stem cells, lung pathogenesis and therapeutic potential
Source: Annual Congress 2005 - Scientific year in review
Year: 2005
siRNA in animal models
Source: Annual Congress 2005 - Selective gene knockout - the use of small interference RNA
Year: 2005
An integrated culture system for in vitro human airway modeling
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
siRNA in human epithelial cells and macrophages
Source: Annual Congress 2005 - Selective gene knockout - the use of small interference RNA
Year: 2005
Developing a chronic murine model that better reflects the clinical features of the human asthma
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models},
Source: Eur Respir Rev 2013; 22: 302-311
Year: 2013
From cell cultures to autopsies: study on functionality across different experimental models in SARS-CoV-2 infection.
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
In vivo micro-imaging of apoptosis in a murine xenograft model of human lung adenocarcinoma
Source: International Congress 2014 – Thoracic tumours: news from the lab
Year: 2014
Evaluation of nanoparticles in human lung fibroblasts and PCLS
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Source: Eur Respir J 2009; 33: 489-506
Year: 2009
What can we learn from animal models?
Source: ERS Research Seminar
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept